Skip to Main Content
TABLE 2

Results for the mean A1C in either the conventional, intensive, or combined treatment groups (stage 1) for any SNP with P < 10−6

ChromosomeSNPPositionMean A1C PCommon homozygote
Heterozygote
Rare homozygote
A1A2Minor allele frequencyMissing data*Hardy-Weinberg equilibrium PLocation of SNP to the nearest gene
nMean ± SDnMean ± SDnMean ± SD
Conventional treatment group                
    9 rs10810632 16,779,024 3.7 × 10−7 576 8.96 ± 1.22 85 9.63 ± 1.22 5 10.63 ± 1.35 C T 0.079 1 0.70 Intron 1 BNC2 
    9 rs6475082 16,779,436 7.4 × 10−7 575 8.96 ± 1.22 86 9.61 ± 1.23 5 10.63 ± 1.35 G A 0.079 1 0.71 Intron 1 BNC2 
    9 rs4961760 16,779,878 7.1 × 10−7 575 8.96 ± 1.22 87 9.61 ± 1.22 5 10.63 ± 1.35 C T 0.080 0 0.71 Intron 1 BNC2 
    10 rs1358030 108,113,589 5.4 × 10−9 268 8.71 ± 1.15 307 9.24 ± 1.25 90 9.44 ± 1.24 C T 0.361 2 0.12 3′ SORCS1 
    18 rs163061 22,727,740 9.7 × 10−7 350 8.83 ± 1.17 259 9.29 ± 1.26 35 9.62 ± 1.43 G C 0.262 40 0.34 3′ C18orf16 
Intensive treatment group                
    15 rs493218 51,277,554 5.4 × 10−7 506 7.31 ± 0.96 120 7.01 ± 0.89 11 6.38 ± 0.69 C T 0.109 2 0.20 3′ WDR72 
    15 rs572221 51,291,924 6.8 × 10−7 504 7.31 ± 0.96 120 7.01 ± 0.89 11 6.38 ± 0.69 A G 0.110 2 0.25 3′ WDR72 
    15 rs690271 51,291,964 5.1 × 10−7 505 7.31 ± 0.96 121 7.01 ± 0.88 11 6.38 ± 0.69 A G 0.110 0 0.26 3′ WDR72 
    15 rs566369 51,295,884 5.1 × 10−7 505 7.31 ± 0.96 121 7.01 ± 0.88 11 6.38 ± 0.69 A G 0.110 1 0.26 3′ WDR72 
    15 rs482541 51,296,486 5.1 × 10−7 505 7.31 ± 0.96 121 7.01 ± 0.88 11 6.38 ± 0.69 A G 0.110 1 0.26 3′ WDR72 
Combined treatment groups                
    5 rs286405 35,613,014 6.7 × 10−7 421 7.99 ± 1.32 631 8.18 ± 1.48 233 8.55 ± 1.68 T C 0.427 19 0.95 5′ FLJ23577 
    10 rs1358030 108,113,589 2.2 × 10−9 545 7.93 ± 1.32 574 8.35 ± 1.57 183 8.48 ± 1.53 C T 0.361 2 0.12 3′ SORCS1 
ChromosomeSNPPositionMean A1C PCommon homozygote
Heterozygote
Rare homozygote
A1A2Minor allele frequencyMissing data*Hardy-Weinberg equilibrium PLocation of SNP to the nearest gene
nMean ± SDnMean ± SDnMean ± SD
Conventional treatment group                
    9 rs10810632 16,779,024 3.7 × 10−7 576 8.96 ± 1.22 85 9.63 ± 1.22 5 10.63 ± 1.35 C T 0.079 1 0.70 Intron 1 BNC2 
    9 rs6475082 16,779,436 7.4 × 10−7 575 8.96 ± 1.22 86 9.61 ± 1.23 5 10.63 ± 1.35 G A 0.079 1 0.71 Intron 1 BNC2 
    9 rs4961760 16,779,878 7.1 × 10−7 575 8.96 ± 1.22 87 9.61 ± 1.22 5 10.63 ± 1.35 C T 0.080 0 0.71 Intron 1 BNC2 
    10 rs1358030 108,113,589 5.4 × 10−9 268 8.71 ± 1.15 307 9.24 ± 1.25 90 9.44 ± 1.24 C T 0.361 2 0.12 3′ SORCS1 
    18 rs163061 22,727,740 9.7 × 10−7 350 8.83 ± 1.17 259 9.29 ± 1.26 35 9.62 ± 1.43 G C 0.262 40 0.34 3′ C18orf16 
Intensive treatment group                
    15 rs493218 51,277,554 5.4 × 10−7 506 7.31 ± 0.96 120 7.01 ± 0.89 11 6.38 ± 0.69 C T 0.109 2 0.20 3′ WDR72 
    15 rs572221 51,291,924 6.8 × 10−7 504 7.31 ± 0.96 120 7.01 ± 0.89 11 6.38 ± 0.69 A G 0.110 2 0.25 3′ WDR72 
    15 rs690271 51,291,964 5.1 × 10−7 505 7.31 ± 0.96 121 7.01 ± 0.88 11 6.38 ± 0.69 A G 0.110 0 0.26 3′ WDR72 
    15 rs566369 51,295,884 5.1 × 10−7 505 7.31 ± 0.96 121 7.01 ± 0.88 11 6.38 ± 0.69 A G 0.110 1 0.26 3′ WDR72 
    15 rs482541 51,296,486 5.1 × 10−7 505 7.31 ± 0.96 121 7.01 ± 0.88 11 6.38 ± 0.69 A G 0.110 1 0.26 3′ WDR72 
Combined treatment groups                
    5 rs286405 35,613,014 6.7 × 10−7 421 7.99 ± 1.32 631 8.18 ± 1.48 233 8.55 ± 1.68 T C 0.427 19 0.95 5′ FLJ23577 
    10 rs1358030 108,113,589 2.2 × 10−9 545 7.93 ± 1.32 574 8.35 ± 1.57 183 8.48 ± 1.53 C T 0.361 2 0.12 3′ SORCS1 

A1C values are %. Mean = mean A1C value, SD = standard deviation of A1C values. A1 = minor, A2 = major allele.

*Number of individuals with missing genotype data. Asymptotic P values from the 2df normal score test. Position is the nucleotide location from build 36.3.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept